Engineered immune cells take on tough lymphoma
Disease control
Ongoing
This early-stage study tests a new treatment for people with non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The approach uses a patient's own T cells, which are modified in a lab to recognize and attack cancer cells, then infused back in…
Phase: PHASE1 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC